GOWell Energy Technology has acquired WellSense Holdings Ltd, a leader in fiber optic sensing and well integrity diagnostics, to enhance its global well-logging solutions. This acquisition expands GOWell's capabilities from point measurements to continuous distributed fiber optic sensing, improving precision in detecting well problems. Funded by GOWell's cash reserves, the deal combines WellSense's innovative technology with GOWell's global reach, aiming for operational excellence and long-term growth in international energy markets.
GOWell's acquisition of WellSense to enhance fiber optic sensing capabilities comes with this snapshot of the Energy sector on Pluang. For readers following Energy stocks, here is Pluang's market snapshot as of Nov 11, 2026 18:41 WIB: Out of 79 priced US Energy stocks, 57 rose and 11 fell. Notable movers include First Solar, Inc. (FSLR) at USD 184.47 with a 1-day change of +1.96% and a typical hold time of 76 days, Baker Hughes Co (BKR) at USD 48.67 with a +1.88% change and 100% buy order activity, and Sunrun Inc (RUN) at USD 8.87 with a +1.84% change but 93% sell order activity.
NRx Pharmaceuticals has begun selling a new preservative-free ketamine made in the U.S., addressing a shortage that has persisted since 2018. This ketamine uses innovative blow-fill-seal technology, eliminating the preservative benzethonium chloride,...
FLSmidth & Co. A/S announced its financial calendar for 2027, including key dates for the annual report, interim financial reports, and the annual general meeting. The company emphasizes its commitment to sustainability with its MissionZero goal to a...
Dimensional Fund Advisors Ltd. has filed a Form 8.3 disclosure revealing it holds a 1.27% stake in Prologis Inc, totaling 12,054,886 shares as of November 10, 2026. This disclosure is part of regulatory requirements under the Takeover Code, indicatin...
Dimensional Fund Advisors Ltd. has filed a disclosure showing it holds a 1.61% stake in DCC Energy plc's ordinary shares as of November 10, 2026. The firm sold 42,998 shares recently at a price of £64.5585 each. This disclosure is part of regulatory ...
Novo Nordisk has committed $200 million to the World Diabetes Foundation for 2027–2036 to enhance diabetes prevention and care in low- and middle-income countries. This funding aims to improve equitable access to diabetes services in underserved comm...
